Nexalin Technology, Inc. announced on February 10, 2025, its appointment as Industry Co-Chair of the National Traumatic Brain Injury (TBI) Registry Coalition. This role underscores Nexalin's commitment to advancing TBI advocacy and research, particularly through collaboration with policymakers and stakeholders in Washington, D.C.
CEO Mark White stated that this appointment reflects the company's dedication to improving the lives of those affected by traumatic brain injuries. Nexalin is committed to working closely with policymakers to advance solutions for this underserved population, especially given projected increases in federal spending on TBI.
This leadership position complements Nexalin's ongoing initiatives, including a collaborative study with the University of California, San Diego (UCSD) and the San Diego Veterans Affairs (VA) to explore innovative treatments for veterans suffering from TBI. The company has also been engaging with legislators to strengthen relationships with federal agencies to enhance TBI care and support.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.